These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 31695458)
1. Regulation of alternative splicing in obesity-induced hypertension. Dlamini Z; Hull R; Makhafola TJ; Mbele M Diabetes Metab Syndr Obes; 2019; 12():1597-1615. PubMed ID: 31695458 [TBL] [Abstract][Full Text] [Related]
2. Genetics of non-syndromic childhood obesity and the use of high-throughput DNA sequencing technologies. da Fonseca ACP; Mastronardi C; Johar A; Arcos-Burgos M; Paz-Filho G J Diabetes Complications; 2017 Oct; 31(10):1549-1561. PubMed ID: 28735903 [TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of obesity hypertension. Hall JE Curr Hypertens Rep; 2000 Apr; 2(2):139-47. PubMed ID: 10981140 [TBL] [Abstract][Full Text] [Related]
4. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888 [TBL] [Abstract][Full Text] [Related]
5. Role of sympathetic nervous system and neuropeptides in obesity hypertension. Hall JE; Brands MW; Hildebrandt DA; Kuo J; Fitzgerald S Braz J Med Biol Res; 2000 Jun; 33(6):605-18. PubMed ID: 10829088 [TBL] [Abstract][Full Text] [Related]
9. Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery. Shariq OA; McKenzie TJ Gland Surg; 2020 Feb; 9(1):80-93. PubMed ID: 32206601 [TBL] [Abstract][Full Text] [Related]
10. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. Esler M; Kaye D J Cardiovasc Pharmacol; 2000; 35(7 Suppl 4):S1-7. PubMed ID: 11346214 [TBL] [Abstract][Full Text] [Related]
11. Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension. Rust P; Ekmekcioglu C Adv Exp Med Biol; 2017; 956():61-84. PubMed ID: 27757935 [TBL] [Abstract][Full Text] [Related]
12. Obesity-Induced Hypertension: Brain Signaling Pathways. do Carmo JM; da Silva AA; Wang Z; Fang T; Aberdein N; de Lara Rodriguez CE; Hall JE Curr Hypertens Rep; 2016 Jul; 18(7):58. PubMed ID: 27262997 [TBL] [Abstract][Full Text] [Related]
13. Pathophysiology and treatment of obesity hypertension. Wofford MR; Hall JE Curr Pharm Des; 2004; 10(29):3621-37. PubMed ID: 15579059 [TBL] [Abstract][Full Text] [Related]
14. Obesity-associated hypertension and kidney disease. Hall JE; Kuo JJ; da Silva AA; de Paula RB; Liu J; Tallam L Curr Opin Nephrol Hypertens; 2003 Mar; 12(2):195-200. PubMed ID: 12589181 [TBL] [Abstract][Full Text] [Related]
15. The future of antihypertensive treatment. Israili ZH; Hernández-Hernández R; Valasco M Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance. Masuo K; Rakugi H; Ogihara T; Esler MD; Lambert GW Curr Diabetes Rev; 2010 Mar; 6(2):58-67. PubMed ID: 20034369 [TBL] [Abstract][Full Text] [Related]
17. Obesity hypertension: role of leptin and sympathetic nervous system. Hall JE; Hildebrandt DA; Kuo J Am J Hypertens; 2001 Jun; 14(6 Pt 2):103S-115S. PubMed ID: 11411745 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of hypertension in obesity]. Scholze J; Sharma AM Herz; 2001 May; 26(3):209-21. PubMed ID: 11413801 [TBL] [Abstract][Full Text] [Related]
19. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches. Reisin E; Jack AV Med Clin North Am; 2009 May; 93(3):733-51. PubMed ID: 19427502 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of hypertension and kidney disease in obesity. Hall JE; Brands MW; Henegar JR Ann N Y Acad Sci; 1999 Nov; 892():91-107. PubMed ID: 10842655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]